Genetic polymorphisms in chemokines CCL5 (RANTES) and CXCL12 (SDF1), which act as potent blockers of HIV infection by competing with the virus for binding to CCR5 and CXCR4 receptors respectively, have been described to be associated with HIV disease progression. This evidence concerns the gene CCL5 and HIV infectious disease.